ライフサイエンスコーパス: differentiated thyroid carcinoma

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ion and radioiodine therapy in patients with differentiated thyroid carcinoma.

2 f thyroid remnants after a thyroidectomy for differentiated thyroid carcinoma.

3 ergone total or near-total thyroidectomy for differentiated thyroid carcinoma.

4 most frequent sites of distant metastasis in differentiated thyroid carcinoma.

5 stunning on the efficacy of 131I therapy for differentiated thyroid carcinoma.

6 sed for treatment of suspected recurrence of differentiated thyroid carcinoma.

7 iodine-positive metastases in patients with differentiated thyroid carcinoma.

8 Hurthle's cell carcinoma, and 21% of poorly differentiated thyroid carcinomas.

9 Following thyroidectomy for differentiated thyroid carcinoma, 50 patients underwent

10 ients with biochemical evidence of recurrent differentiated thyroid carcinoma and a tumor-negative ne

11 thyroidectomized patients with a history of differentiated thyroid carcinoma are presented who had n

12 Differentiated thyroid carcinomas are the most frequent

13 ts relationship to the widely prevalent well-differentiated thyroid carcinomas are unclear.

14 Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased

15 is frequently used after a thyroidectomy for differentiated thyroid carcinoma because it has been rep

16 otein galectin-3 is widely expressed in well-differentiated thyroid carcinomas, but not in normal thy

17 human papillary, Hurthle's cell, and poorly differentiated thyroid carcinoma by epigenetic and bioch

18 id tumors (for example, anaplastic or poorly differentiated thyroid carcinoma) carry several complex

19 In some patients with well-differentiated thyroid carcinoma, dosimetry is necessary

20 en found useful at stratifying patients with differentiated thyroid carcinoma (DTC) into prognostic r

21 The overall prognosis in pediatric differentiated thyroid carcinoma (DTC) is excellent.

22 /CT in detecting recurrence or metastases in differentiated thyroid carcinoma (DTC) patients with ele

23 Differentiated thyroid carcinoma (DTC), as one of the ma

24 of cardiovascular mortality in patients with differentiated thyroid carcinoma (DTC).

25 evious reports, the majority of these poorly differentiated thyroid carcinomas express E-cadherin, bu

26 Two patients with advanced, well-differentiated thyroid carcinoma illustrate the need for

27 The well-differentiated thyroid carcinomas include papillary and

28 Iodine-131 scintigraphy for differentiated thyroid carcinoma is more sensitive and m

29 on-frozen-section group, 3 (10%) showed well-differentiated thyroid carcinoma on permanent histology.

30 devascularized during thyroidectomy for well-differentiated thyroid carcinoma or benign disease shoul

31 o independent predictors of poor survival in differentiated thyroid carcinomas (P =.027 and P =.007,

32 nvasive and have well-defined foci of poorly differentiated thyroid carcinoma (PDTC).

33 consecutive post-thyroidectomy patients for differentiated thyroid carcinoma received a 185-MBq (5 m

34 f 18 years or older; total thyroidectomy for differentiated thyroid carcinoma; tumor-node-metastasis

35 f (131)I for treatment of patients with well-differentiated thyroid carcinoma; usual amounts vary wid

36 166 patients who underwent thyroidectomy for differentiated thyroid carcinoma was performed.

37 Among patients with differentiated thyroid carcinomas (WDC and PDC), 11 (55.

38 ent 131I therapy following thyroidectomy for differentiated thyroid carcinoma were enrolled, along wi

39 n progression-free survival in patients with differentiated thyroid carcinoma who were less than 21 y

40 hway may promote redifferentiation in poorly differentiated thyroid carcinomas with constitutive acti

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。